Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Colorcon
Cipla
Teva
Queensland Health
Boehringer Ingelheim
US Department of Justice
Farmers Insurance

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SAXAGLIPTIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Saxagliptin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00121641 Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Completed AstraZeneca Phase 3 The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise
NCT00121667 Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone Completed AstraZeneca Phase 3 The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone
NCT00295633 A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone Completed AstraZeneca Phase 3 The purpose of this clinical research study is to learn whether Saxagliptin added to thiazolidinedione (TZD) therapy is more effective than TZD alone as a treatment for Type 2 diabetic subjects who are not sufficiently controlled with TZD alone
NCT00313313 A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas Completed AstraZeneca Phase 3 The purpose of this trial is to understand if adding saxagliptin to a sulfonylurea is safe and works better than increasing the amount of sulfonylurea a patient takes
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Saxagliptin Hydrochloride

Condition Name

Condition Name for Saxagliptin Hydrochloride
Intervention Trials
Type 2 Diabetes Mellitus 31
Type 2 Diabetes 30
Diabetes Mellitus, Type 2 13
Diabetes 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Saxagliptin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 86
Diabetes Mellitus 83
Glucose Intolerance 5
Heart Failure 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Saxagliptin Hydrochloride

Trials by Country

Trials by Country for Saxagliptin Hydrochloride
Location Trials
United States 475
Canada 79
Mexico 67
India 44
China 44
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Saxagliptin Hydrochloride
Location Trials
Texas 34
California 27
Florida 22
Ohio 20
South Carolina 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Saxagliptin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Saxagliptin Hydrochloride
Clinical Trial Phase Trials
Phase 4 36
Phase 3 40
Phase 2/Phase 3 1
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Saxagliptin Hydrochloride
Clinical Trial Phase Trials
Completed 63
Recruiting 22
Not yet recruiting 11
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Saxagliptin Hydrochloride

Sponsor Name

Sponsor Name for Saxagliptin Hydrochloride
Sponsor Trials
AstraZeneca 70
Bristol-Myers Squibb 17
Canadian Network for Observational Drug Effect Studies, CNODES 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Saxagliptin Hydrochloride
Sponsor Trials
Industry 91
Other 79
NIH 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Johnson and Johnson
Baxter
Cerilliant
Argus Health
AstraZeneca
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.